BR9712575A - Processo para restaurar em células que apresentam uma proteìna p53 que sofreu mutação , uma atividade de transactivação p53-dependente, utilizações de um anticorpo de cadeia simples capaz de ligar especificamente uma proteìna p53 que sofreu mutação, e de um ácido nucleico codificante, molécula 11d3 ou uma variante, ácido nucleico e composição - Google Patents
Processo para restaurar em células que apresentam uma proteìna p53 que sofreu mutação , uma atividade de transactivação p53-dependente, utilizações de um anticorpo de cadeia simples capaz de ligar especificamente uma proteìna p53 que sofreu mutação, e de um ácido nucleico codificante, molécula 11d3 ou uma variante, ácido nucleico e composiçãoInfo
- Publication number
- BR9712575A BR9712575A BR9712575-0A BR9712575A BR9712575A BR 9712575 A BR9712575 A BR 9712575A BR 9712575 A BR9712575 A BR 9712575A BR 9712575 A BR9712575 A BR 9712575A
- Authority
- BR
- Brazil
- Prior art keywords
- protein
- nucleic acid
- mutated
- variant
- molecule
- Prior art date
Links
- 108020004707 nucleic acids Proteins 0.000 title abstract 4
- 102000039446 nucleic acids Human genes 0.000 title abstract 4
- 150000007523 nucleic acids Chemical class 0.000 title abstract 4
- 230000000694 effects Effects 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
- 230000023603 positive regulation of transcription initiation, DNA-dependent Effects 0.000 title abstract 2
- 230000001419 dependent effect Effects 0.000 title 1
- 230000004568 DNA-binding Effects 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 abstract 1
- 238000000338 in vitro Methods 0.000 abstract 1
- 238000001727 in vivo Methods 0.000 abstract 1
- 230000035772 mutation Effects 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 108091006106 transcriptional activators Proteins 0.000 abstract 1
- 210000004881 tumor cell Anatomy 0.000 abstract 1
- 239000013598 vector Substances 0.000 abstract 1
- 239000002699 waste material Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4746—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used p53
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
''PROCESSO PARA RESTAURAR EM CéLULAS QUE APRESENTAM UMA PROTEìNA P53, QUE SOFREU MUTAçãO, UMA ATIVIDADE DE TRANSACTIVAçãO P53-DEPENDENTE, UTILIZAçõES DE UMA ANTICORPO DE CADEIA SIMPLES CAPAZ DE LIGAR ESPECIFICAMENTE UMA PROTEìNA P53 QUE SOFREU MUTAçãO, E DE UM áCIDO NUCLEICO CODIFICANTE, MOLéCULA 11D3 OU UMA VARIANTE, áCIDO NUCLEICO E COMPOSIçãO''. A presente invenção refere-se aos anticorpos com cadeia única dirigidos contra a proteína p53, capazes de serem expressos em células tumorais, capazes de restaurar uma função de ligação de DNA in vitro e uma função de ativador transcripcional in vivo. Ela se refere igualmente aos ácidos nucleicos codificantes para estas moléculas, aos vetores que os contêm e suas utilizações.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9613176A FR2755144B1 (fr) | 1996-10-29 | 1996-10-29 | Fragments d'anticorps a chaine unique anti-p53 et utilisation |
| PCT/FR1997/001921 WO1998018825A1 (fr) | 1996-10-29 | 1997-10-27 | Fragments d'anticorps a chaine unique anti-p53 et utilisations |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR9712575A true BR9712575A (pt) | 1999-10-19 |
Family
ID=9497134
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR9712575-0A BR9712575A (pt) | 1996-10-29 | 1997-10-27 | Processo para restaurar em células que apresentam uma proteìna p53 que sofreu mutação , uma atividade de transactivação p53-dependente, utilizações de um anticorpo de cadeia simples capaz de ligar especificamente uma proteìna p53 que sofreu mutação, e de um ácido nucleico codificante, molécula 11d3 ou uma variante, ácido nucleico e composição |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US6852509B1 (pt) |
| EP (1) | EP0941252B1 (pt) |
| JP (1) | JP4371178B2 (pt) |
| KR (1) | KR100874789B1 (pt) |
| AT (1) | ATE380198T1 (pt) |
| AU (1) | AU745530B2 (pt) |
| BR (1) | BR9712575A (pt) |
| CA (1) | CA2268865C (pt) |
| CZ (1) | CZ300526B6 (pt) |
| DE (1) | DE69738352T2 (pt) |
| DK (1) | DK0941252T3 (pt) |
| ES (1) | ES2297853T3 (pt) |
| FR (1) | FR2755144B1 (pt) |
| HU (1) | HU226330B1 (pt) |
| IL (2) | IL129476A0 (pt) |
| NO (1) | NO326452B1 (pt) |
| PT (1) | PT941252E (pt) |
| SI (1) | SI0941252T1 (pt) |
| SK (1) | SK286978B6 (pt) |
| WO (1) | WO1998018825A1 (pt) |
| ZA (1) | ZA979738B (pt) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL121041A0 (en) | 1997-06-09 | 1997-11-20 | Yeda Res & Dev | Immunogenic compositions for induction of anti-tumor immunity |
| US7199809B1 (en) | 1998-10-19 | 2007-04-03 | Symyx Technologies, Inc. | Graphic design of combinatorial material libraries |
| AUPP932199A0 (en) * | 1999-03-19 | 1999-04-15 | St Vincent's Hospital Sydney Limited | Anti-p53 antibodies |
| AU769679B2 (en) * | 1999-03-19 | 2004-01-29 | St Vincent's Hospital Sydney Limited | Anti-p53 antibodies |
| DE19962583A1 (de) * | 1999-12-23 | 2001-06-28 | Mueller Hermelink Hans Konrad | Antikörper gegen Plasmazellen |
| US6630584B1 (en) * | 2000-03-16 | 2003-10-07 | Ramot At Tel-Aviv University Ltd. | Single chain antibody against mutant p53 |
| JPWO2005061007A1 (ja) * | 2003-12-24 | 2007-07-12 | 学校法人 聖マリアンナ医科大学 | 癌の抑制方法 |
| JPWO2005061001A1 (ja) * | 2003-12-24 | 2007-07-12 | 株式会社ロコモジェン | 癌の抑制方法 |
| GB0420771D0 (en) * | 2004-09-17 | 2004-10-20 | Randox Lab Ltd | Antibody |
| ATE437185T1 (de) | 2005-03-25 | 2009-08-15 | Univ Ramot | Gegen das gemeinsame epitop von mutierten p53 gerichtete humane synthetische einzelkettenantikörper und anwendungen davon |
| WO2007028117A2 (en) * | 2005-09-02 | 2007-03-08 | New England Medical Center Hospitals, Inc. | P8 as a marker for heart failure |
| WO2017191560A1 (en) * | 2016-05-02 | 2017-11-09 | Prothena Biosciences Limited | Antibodies recognizing tau |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9224784D0 (en) * | 1992-11-26 | 1993-01-13 | Univ Dundee | Cellular protein |
| FR2732348B1 (fr) * | 1995-03-31 | 1997-04-30 | Rhone Poulenc Rorer Sa | Systeme d'expression conditionnel |
| FR2736915B1 (fr) | 1995-07-19 | 1997-08-22 | Rhone Poulenc Rorer Sa | Variants de la proteine p53 et utilisations therapeutiques |
-
1996
- 1996-10-29 FR FR9613176A patent/FR2755144B1/fr not_active Expired - Fee Related
-
1997
- 1997-10-27 WO PCT/FR1997/001921 patent/WO1998018825A1/fr active IP Right Grant
- 1997-10-27 US US09/297,181 patent/US6852509B1/en not_active Expired - Fee Related
- 1997-10-27 DK DK97912262T patent/DK0941252T3/da active
- 1997-10-27 KR KR1019997003679A patent/KR100874789B1/ko not_active IP Right Cessation
- 1997-10-27 SK SK558-99A patent/SK286978B6/sk not_active IP Right Cessation
- 1997-10-27 AT AT97912262T patent/ATE380198T1/de active
- 1997-10-27 DE DE69738352T patent/DE69738352T2/de not_active Expired - Lifetime
- 1997-10-27 SI SI9730778T patent/SI0941252T1/sl unknown
- 1997-10-27 JP JP52011998A patent/JP4371178B2/ja not_active Expired - Fee Related
- 1997-10-27 AU AU49520/97A patent/AU745530B2/en not_active Ceased
- 1997-10-27 CA CA2268865A patent/CA2268865C/fr not_active Expired - Fee Related
- 1997-10-27 BR BR9712575-0A patent/BR9712575A/pt not_active Application Discontinuation
- 1997-10-27 ES ES97912262T patent/ES2297853T3/es not_active Expired - Lifetime
- 1997-10-27 PT PT97912262T patent/PT941252E/pt unknown
- 1997-10-27 CZ CZ0145599A patent/CZ300526B6/cs not_active IP Right Cessation
- 1997-10-27 EP EP97912262A patent/EP0941252B1/fr not_active Expired - Lifetime
- 1997-10-27 IL IL12947697A patent/IL129476A0/xx unknown
- 1997-10-27 HU HU9904199A patent/HU226330B1/hu not_active IP Right Cessation
- 1997-10-29 ZA ZA9709738A patent/ZA979738B/xx unknown
-
1999
- 1999-04-13 NO NO19991729A patent/NO326452B1/no not_active IP Right Cessation
- 1999-04-15 IL IL129476A patent/IL129476A/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| HUP9904199A1 (hu) | 2000-04-28 |
| DE69738352D1 (de) | 2008-01-17 |
| KR100874789B1 (ko) | 2008-12-18 |
| NO991729D0 (no) | 1999-04-13 |
| WO1998018825A1 (fr) | 1998-05-07 |
| NO991729L (no) | 1999-04-13 |
| SI0941252T1 (sl) | 2008-04-30 |
| DK0941252T3 (da) | 2008-03-31 |
| IL129476A (en) | 2010-05-17 |
| CZ145599A3 (cs) | 1999-08-11 |
| IL129476A0 (en) | 2000-02-29 |
| JP4371178B2 (ja) | 2009-11-25 |
| ZA979738B (en) | 1998-05-22 |
| SK55899A3 (en) | 2000-06-12 |
| DE69738352T2 (de) | 2008-11-13 |
| FR2755144A1 (fr) | 1998-04-30 |
| CA2268865A1 (fr) | 1998-05-07 |
| PT941252E (pt) | 2008-03-07 |
| EP0941252B1 (fr) | 2007-12-05 |
| EP0941252A1 (fr) | 1999-09-15 |
| CZ300526B6 (cs) | 2009-06-10 |
| CA2268865C (fr) | 2011-01-04 |
| FR2755144B1 (fr) | 1998-11-27 |
| ES2297853T3 (es) | 2008-05-01 |
| HUP9904199A3 (en) | 2000-09-28 |
| US6852509B1 (en) | 2005-02-08 |
| AU745530B2 (en) | 2002-03-21 |
| JP2001502553A (ja) | 2001-02-27 |
| ATE380198T1 (de) | 2007-12-15 |
| SK286978B6 (sk) | 2009-08-06 |
| AU4952097A (en) | 1998-05-22 |
| NO326452B1 (no) | 2008-12-08 |
| HU226330B1 (en) | 2008-09-29 |
| KR20000052845A (ko) | 2000-08-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Atasever et al. | One-step purification of lactoperoxidase from bovine milk by affinity chromatography | |
| BR9712575A (pt) | Processo para restaurar em células que apresentam uma proteìna p53 que sofreu mutação , uma atividade de transactivação p53-dependente, utilizações de um anticorpo de cadeia simples capaz de ligar especificamente uma proteìna p53 que sofreu mutação, e de um ácido nucleico codificante, molécula 11d3 ou uma variante, ácido nucleico e composição | |
| BR9710968A (pt) | Antìgenos de célula b humana; reagentes correlatos | |
| Murphy et al. | Clathrin assembly protein AP-3: The identity of the 155K protein, AP 180, and NP185 and demonstration of a clathrin binding domain | |
| DE69904511D1 (de) | Proteinmaterial mit verlangsamtem verdaungsablauf und deren verwendung | |
| ID23855A (id) | Protein pengikat osteoprotegerin dan reseptor | |
| NZ323795A (en) | Isolated nucleic acid molecules encoding AUR-1 (aurora-1) and AUR-2 polypeptides | |
| BRPI9707379C8 (pt) | composições farmacêuticas compreendendo anticorpo humano recombinante geneticamente engenheirado, e anticorpo humano recombinante geneticamente engenheirado. | |
| DE69621953T2 (de) | Vehikel zum einbringen von nukleinsäuren in zellen | |
| DK1005540T3 (da) | IKK-beta-proteiner, nukleinsyrer og fremgangsmåder | |
| ATE135371T1 (de) | Mit akuter pankreatitis assoziiertes protein, mittel zur diagnose von akuter pankreatitis | |
| WO2003065003A3 (en) | Nuclear matrix protein alterations associated with colon cancer and colon metastasis to the liver, and uses thereof | |
| WO1999025878A3 (en) | Methods for modulating and identifying cellular senescence | |
| CA2281895A1 (en) | Ikb kinases | |
| WO1994021800A3 (en) | Protein tyrosine phosphatase ptp-s31 | |
| PE20021098A1 (es) | ANTICUERPOS ESPECIFICOS DE CD44v6 | |
| ATE348171T1 (de) | Proteine mit lecithin-cholesterin acetyltransferase-ähnlicher aktivität, deren herstellung und verwendung | |
| DE69732857D1 (de) | Nukleinsaeuren und proteine der katze fc-epsilon rezeptor alpha-kette und deren verwendungen | |
| ATE70916T1 (de) | Mit ueberzuegen versehene formkoerper zur bindung von bioaffinen substanzen. | |
| BR9101117A (pt) | Produto que compreende um ou mais veiculos de material enzimatico e processo para distribuir um agente ativo a um sitio | |
| ATE122723T1 (de) | Retinoblastoma-genprodukt-antikörper und deren verwendungen. | |
| WO2000018803A3 (en) | Antibodies to mammalian langerhans cell antigen and their uses | |
| ATE247710T1 (de) | Genexpression von utrophin | |
| SE8500102D0 (sv) | Forfarande for mikrofloraavlossning | |
| RÖMER-LÜTHI et al. | Molecular forms of purified human erythrocyte membrane acetylcholinesterase investigated by crosslinking with diimidates |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: DE ACORDO COM O ART. 37, INDEFIRO O PRESENTE PEDIDO COM BASE NO ARTS. 8O, 10(IX), 13, 24 E 25 DA LPI VIGENTE. |
|
| B12B | Appeal against refusal [chapter 12.2 patent gazette] | ||
| B25D | Requested change of name of applicant approved |
Owner name: AVENTIS PHARMA S.A. (FR) Free format text: NOME ALTERADO DE: RHONE-POULENC RORER S.A. |